PMC:7600245 / 20917-21185 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-FMA-UBERON

    {"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T94","span":{"begin":23,"end":28},"obj":"Body_part"},{"id":"T95","span":{"begin":234,"end":244},"obj":"Body_part"}],"attributes":[{"id":"A94","pred":"fma_id","subj":"T94","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A95","pred":"fma_id","subj":"T95","obj":"http://purl.org/sig/ont/fma/fma7199"}],"text":"akes place in infected cells by a series of bio-transformations similar to those of remdesivir (Figure S2) [67]. The main advantage of the prodrug, relative to the former prodrug, is that it increases the drug’s oral bioavailability, intestinal diffusion, selectivity "}

    LitCovid-PD-CLO

    {"project":"LitCovid-PD-CLO","denotations":[{"id":"T191","span":{"begin":23,"end":28},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T192","span":{"begin":32,"end":33},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"},{"id":"T193","span":{"begin":103,"end":105},"obj":"http://purl.obolibrary.org/obo/CLO_0008922"},{"id":"T194","span":{"begin":103,"end":105},"obj":"http://purl.obolibrary.org/obo/CLO_0050052"},{"id":"T195","span":{"begin":234,"end":244},"obj":"http://purl.obolibrary.org/obo/UBERON_0000160"},{"id":"T196","span":{"begin":234,"end":244},"obj":"http://www.ebi.ac.uk/efo/EFO_0000834"}],"text":"akes place in infected cells by a series of bio-transformations similar to those of remdesivir (Figure S2) [67]. The main advantage of the prodrug, relative to the former prodrug, is that it increases the drug’s oral bioavailability, intestinal diffusion, selectivity "}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T278","span":{"begin":84,"end":94},"obj":"Chemical"},{"id":"T279","span":{"begin":103,"end":105},"obj":"Chemical"},{"id":"T280","span":{"begin":139,"end":146},"obj":"Chemical"},{"id":"T281","span":{"begin":171,"end":178},"obj":"Chemical"}],"attributes":[{"id":"A278","pred":"chebi_id","subj":"T278","obj":"http://purl.obolibrary.org/obo/CHEBI_145994"},{"id":"A279","pred":"chebi_id","subj":"T279","obj":"http://purl.obolibrary.org/obo/CHEBI_29387"},{"id":"A280","pred":"chebi_id","subj":"T280","obj":"http://purl.obolibrary.org/obo/CHEBI_50266"},{"id":"A281","pred":"chebi_id","subj":"T281","obj":"http://purl.obolibrary.org/obo/CHEBI_50266"}],"text":"akes place in infected cells by a series of bio-transformations similar to those of remdesivir (Figure S2) [67]. The main advantage of the prodrug, relative to the former prodrug, is that it increases the drug’s oral bioavailability, intestinal diffusion, selectivity "}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"567","span":{"begin":84,"end":94},"obj":"Chemical"},{"id":"580","span":{"begin":14,"end":22},"obj":"Disease"}],"attributes":[{"id":"A567","pred":"tao:has_database_id","subj":"567","obj":"MESH:C000606551"},{"id":"A580","pred":"tao:has_database_id","subj":"580","obj":"MESH:D007239"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"akes place in infected cells by a series of bio-transformations similar to those of remdesivir (Figure S2) [67]. The main advantage of the prodrug, relative to the former prodrug, is that it increases the drug’s oral bioavailability, intestinal diffusion, selectivity "}